Lung Cancer Screening in Poland Pilot Program Is Restarted After COVID-19 Lockdown

FDA’s Project Patient Voice Launched to Provide Data on PROs

Multidisciplinary EURACAN/IASLC Proposal for Revision of the Histologic Classification of Malignant Pleural Mesothelioma 

Controversy Regarding U.S. Marketing of New Heated Tobacco Product IQOS

A New Year’s Resolution to Promote the Use of Patient-Sensitive Language

WCLC Conference Chairs Offer Insights on The New All-Virtual Program, The Year Ahead

2020 Adi F. Gazdar IASLC Merit Award Recipient: Dr. Alex A. Adjei

Role of Thai Oncology Pharmacists in Lung Cancer Treatment: A Q&A With Dr. Suthan Chanthawong

PD-L1 Blockade Reinvigorates Dendritic Cells for Antitumor Immunity

Research’s Race to Stop a Pandemic

Should We Delay Lung Cancer Screening During the COVID-19 Pandemic?

Improving Molecular Testing in Lung Cancer: What We Learned From the IASLC Global Survey